To hear about similar clinical trials, please enter your email below
Trial Title:
Meaning-Centered Psychotherapy at Home
NCT ID:
NCT05495737
Condition:
Nurse-Patient Relations
Psychology, Social
Conditions: Keywords:
Meaning Centered Psychotherapy
Meaning Centered Psychotherapy for Palliative Patients
22-019
Memorial Sloan Kettering Cancer Center
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Behavioral
Intervention name:
Meaning-Centered Psychotherapy/MCP-PC Training
Description:
Two-Day MCP-PC Training for Nurses (including mock patient/simulation with actor) with a
Pre- and Post-Training Assessment
Arm group label:
Phase 1: Nurse Participants
Arm group label:
Phase 2: Nurse Participants
Intervention type:
Behavioral
Intervention name:
Meaning-Centered Psychotherapy/MCP-PC
Description:
3 sessions, completed over the course of 3-6 weeks in the participant's home
Arm group label:
Phase 1: Patient Participants
Arm group label:
Phase 2: Patient Participants Meaning-Centered Psychotherapy/MCP-PC Intervention Arm
Intervention type:
Behavioral
Intervention name:
Treatment As Usual/TAU
Description:
Research team will provide:
1. feedback about level of distress at time of screening
2. local referral for psychological care
Arm group label:
Phase 2: Patient Participants Treatment As Usual/TAU Intervention Arm
Summary:
The purpose of this study is to train nurses from the VNS Health Visiting Nurse Service
to deliver Meaning-Centered Psychotherapy for Palliative Care Patients (MCP-PC) to
homebound people, and to evaluate how effective MCP-PC is for people with cancer.
Criteria for eligibility:
Study pop:
Both patients and homecare nurses will be recruited and enrolled as participants in the
proposed study. All participants will be recruited from VNS Health Visiting Nurse Service
Sampling method:
Non-Probability Sample
Criteria:
Participant Inclusion Criteria:
Nurses (all phases):
- Per self-report, providing direct care services at VNS Health
- Per self-report, fluent in English**
- Per self-report, is age 18 or older
Patients (all phases):
- Per health record and/or self-report, is a patient in the VNS Health home health
agency division (post-acute care)
- Per health record and/or self-report, is age 18 or older
- Per health record, has a cancer diagnosis and a rating of ≥ 2 on Symptom Control
Scale
- Per health record and/or self-report, fluent in English**
- Has a score of ≥ 4 on Callahan cognitive screener
- Has a score of ≥ 4 on Distress Thermometer (N/A for Training Case Participants)
- Language verification: For both nurses and patients, prior to enrollment, all
will be asked the following two questions by a Clinical Research Coordinator
(CRC) to verify
English fluency necessary for participation in the study:
1. How well do you speak English? (must respond "very well" or "well" when given the
choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
2. What is your preferred language for healthcare? (must respond English)
Participant Exclusion Criteria:
Nurses (all phases):
- Per self-report, planning to leave position at VNS Health in the next 6 months
Patients (all phases):
- Per health record and/or self-report, has a diagnosis of Alzheimer's, dementia, or
other organic brain disorder and in the judgment of the PIs is unable to
meaningfully participate.
- Per health record, has impaired decision-making capacity
- Per health record and/or self-report, is permanently placed in a nursing home
- Per health record and/or self-report, is currently receiving Hospice care
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Visiting Nurse Service of NY
Address:
City:
New York
Zip:
10021
Country:
United States
Status:
Active, not recruiting
Facility:
Name:
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Address:
City:
New York
Zip:
10065
Country:
United States
Status:
Recruiting
Contact:
Last name:
Rebecca Saracino, PhD
Phone:
646-888-0263
Start date:
August 8, 2022
Completion date:
August 8, 2025
Lead sponsor:
Agency:
Memorial Sloan Kettering Cancer Center
Agency class:
Other
Source:
Memorial Sloan Kettering Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05495737
http://www.mskcc.org
